About Zach Scheiner
Zach Scheiner is a director at Memento Medicines.
Form D filings also name Zach Scheiner as a director at Sparrow Pharmaceuticals and Sydnexis.
Zach Scheiner first appears on SEC filings in 2024.
Experience
This experience comes from Zach Scheiner's profile and from SEC filings. For roles taken from filings, the years are when the filings name Zach Scheiner in the role, so the role may have started earlier or lasted longer.
Memento Medicines, Inc. Current
Board of Directors
2026 – Present · Boston, MA
Develops antibody therapies for people with retinal diseases.
SI
SpyGlass Pharma, Inc. Current
Board of Directors
2023 – Present
NI
Nkarta Therapeutics, Inc Current
Board of Directors
2020 – Present
RM
RA Capital Management Current
Partner (2017 – Present)
Associate / Senior Associate (2015 – 2017)
2015 – Present
EX
Exo
Board of Directors
2021 – 2025
AI
Adagio Medical Inc.
Board of Directors
2020 – 2023
CC
California Institute for Regenerative Medicine (CIRM)
Science Officer
2009 – 2015
TA
The Harrisburg Academy
Middle School Science Teacher
1998 – 2001
Key Colleagues at Startups
The people Zach Scheiner works with at each company, as listed on that company's latest Form D.
Memento Medicines, Inc. · Form D, Jun 16, 2026
WB
William Bonificio
Executive officer and promoter
MK
Megan Krench
Director
ST
Stephen Thomas
Executive officer and promoter
DH
Dmitrij Hristodorov
Director
ND
Naveen Daryani
CEO and director
VK
Vishal Kapoor
Director
Sparrow Pharmaceuticals, Inc. · Form D, Jul 1, 2025
JR
Jonathan Root
Director
ND
Niall O'Donnell
Director
KV
Klaus Veitinger
Director
NN
Nanna L?neborg
Director
PT
Peter Thompson
Director
RJ
Robert Jacks
Chief Executive Officer and director
Sydnexis, Inc. · Form D, Apr 15, 2025
MJ
Mary Johnson
Executive officer
PJ
Patrick Johnson
Executive officer and promoter
PS
Perry Sternberg
CEO and director
JW
Jeffry Weinhuff
Director
TS
Tyler Stowater
Director
Juliet Bakker
Director
RL
Richard Lindstrom
Director